Drawing for REDIMEDS PHARMACY

USPTO serial 76495514

REDIMEDS PHARMACY

Reviewed by CopyMark Law Group

Status 601
Filing date
Status date
Registration date
—
Examiner
LORENZO, GEORGE M
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with REDIMEDS PHARMACY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Keith A. Vogt

KEITH A VOGT NIRO, SCAVONE, HALLER & NIRO181 W MADISON ST STE 4600CHICAGO, IL 60602UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035retail pharmacy services; packaging of dose base medicines and supplies to the order and specification of othersACTIVEMar 1, 2003

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 17, 2003ABN1ABANDONMENT - EXPRESS MAILED—
Nov 14, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 29, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 29, 2003TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 21, 2003CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 20, 2003DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance